Drug Profile
Research programme: monoclonal antibody therapeutics - Bayer Healthcare/Shanghai RAAS Blood Products
Alternative Names: murine immunoglubulin G1/kappaLatest Information Update: 28 Dec 2020
Price :
$50
*
At a glance
- Originator Oklahoma Medical Research Foundation
- Developer Bayer; Oklahoma Medical Research Foundation
- Class Anticoagulants; Monoclonal antibodies
- Mechanism of Action Activated protein C receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Haemophilia